Cargando…

Clinical characteristics and prognostic analysis of SMARCA4‐deficient non‐small cell lung cancer

PURPOSE: To improve the understanding of special types of tumors, we summarized and analyzed the clinicopathological features and prognostic factors of SMARCA4‐deficient non‐small cell lung cancer (SMARCA4‐dNSCLC). METHODS: We selected 105 patients with SMARCA4‐dNSCLC and 221 patients with SMARCA4‐i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Xiyue, Gao, Xianzheng, Wang, Feng, Li, Shenglei, Zhou, Yashu, Guo, Peng, Meng, Yuanyuan, Lu, Taiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358186/ https://www.ncbi.nlm.nih.gov/pubmed/37184108 http://dx.doi.org/10.1002/cam4.6083

Ejemplares similares

SMARCA4‑deficient non‑small cell lung cancer with an EGFR mutation: A case report
por: Sun, Lijun, et al.
Publicado: (2023)

Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
por: Gao, Jie, et al.
Publicado: (2023)

Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
por: Lin, Yun-Tzu, et al.
Publicado: (2023)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

SMARCA4‐deficient lung tumour that presented with haemoptysis and progressed rapidly
por: Inoue, Mari, et al.
Publicado: (2020)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Hyper‐progressive disease after immune checkpoint inhibitor in SMARCA4‐deficient small‐cell lung carcinoma
por: Chiba, Yosuke, et al.
Publicado: (2020)

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients
por: Armon, Subasri, et al.
Publicado: (2021)

TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
por: Mehta, Anurag, et al.
Publicado: (2022)

SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics
por: Al-Shbool, Ghassan, et al.
Publicado: (2022)

SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer
por: Mehta, Anurag, et al.
Publicado: (2021)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma
por: Khanchel, Fatma, et al.
Publicado: (2021)

Is the case really a SMARCA4‐deficient thoracic sarcoma?
por: Kunimasa, Kei
Publicado: (2020)

Case Series of SMARCA4-Deficient Undifferentiated Esophageal Carcinoma
por: Ahmed, Omar T, et al.
Publicado: (2022)

Dynamic and Static (18)F-FDG PET/CT Imaging in SMARCA4-Deficient Non-Small Cell Lung Cancer and Response to Therapy: A Case Report
por: Wumener, Xieraili, et al.
Publicado: (2023)

Thoracic SMARCA4‐deficient undifferentiated tumour: Diagnostic challenges and potential for misdiagnosis in small tissue samples
por: Maartens, Deborah Johanna, et al.
Publicado: (2023)

Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report
por: Naito, Tomoyuki, et al.
Publicado: (2019)

Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
por: Meng, Xiangpeng, et al.
Publicado: (2023)

Response to ‘Is the case really a SMARCA4‐deficient thoracic sarcoma?’
por: Takada, Kohichi, et al.
Publicado: (2020)

SMARCA4-deficient undifferentiated thoracic tumor: A case report
por: Kwon, Hee Jung, et al.
Publicado: (2023)

SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
por: Xue, Yibo, et al.
Publicado: (2019)

Circular RNA SMARCA5 may serve as a tumor suppressor in non‐small cell lung cancer
por: Tong, Suiju
Publicado: (2020)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Two Cases of SMARCA4-Deficient Non-small Cell Lung Cancer (NSCLC) with Improved Performance Status (PS) after Treatment with Immune Checkpoint Inhibitors (ICIs)
por: Koizumi, Akiko, et al.
Publicado: (2023)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site
por: Tono, Yasutaka, et al.
Publicado: (2022)

SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT—Case Report
por: Sirák, Igor, et al.
Publicado: (2021)

A dramatic course after the resection of an SMARCA4‐deficient undifferentiated tumour
por: Iguchi, Takafumi, et al.
Publicado: (2022)

Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)

SMARCA4 deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma
por: Kurashima, Kiminori, et al.
Publicado: (2020)

circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer
por: Cai, Juan, et al.
Publicado: (2019)

SMARCA4-deficient uterine sarcoma: A case report and a concise review
por: Kord, Ali, et al.
Publicado: (2020)

SMARCA4-deficient thoracic tumor detected by [(18)F]FDG PET/CT
por: Okazaki, Tsubasa, et al.
Publicado: (2021)

Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy
por: Kurokawa, Mariko, et al.
Publicado: (2021)

Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report
por: Baa, Annie Kanchan, et al.
Publicado: (2021)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j7jdepi3okb2qa6bpv64b23raq